A new quiescent center appears from actively proliferating cells upon regeneration
Semaglutide, when used for weight loss and not diabetic patients, is specifically approved for adults who have a body mass index (BMI) of 30 or more or a BMI of 27 or more with at least one weight-related medical or health condition like high blood pressure, type 2 diabetes, or even high cholesterol
Journal of physiology and pharmacology: an official journal of the Polish Physiological Society, 60 Suppl 7 , 115122
Semaglutide protects against metabolic syndrome-induced reductions in hippocampal volume and neuronal density We used light microscopy to observe changes in the hippocampus of the animals studied
And the researchers who published it aren't writing editorials saying "maybe worry about this someday" - they're calling for DXA baselines, resistance training, and protein optimization to become standard of care from day one of GLP-1 therapy
You can prepare it either the night before or on the spot
